Medical/Pharmaceuticals

SonoScape's X5 is aboard to deliver ultrasound imaging in Space

SHENZHEN, China, July 19, 2021 /PRNewswire/ -- On June 17th, the Shenzhou-12 spacecraft consisting of a crew of three was launched into space, taking one step forward to establishChina's Tiangong space station which is under construction in a Low-Earth orbit. Astronauts will stay in space for thr...

2021-07-19 15:10 4150

Parkinson's UK Implements CDD Vault to Manage Its Pioneering Drug Discovery Data

LONDON and SAN FRANCISCO, July 19, 2021 /PRNewswire/ -- Parkinson's UK, the largest charitable funder of Parkinson's research inEurope, has announced today that it is using Collaborative Drug Discovery'sCDD Vault informatics system to manage project data from theParkinson's Virtual Biotech, its p...

2021-07-19 14:57 1709

YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE

BEIJING, July 19, 2021 /PRNewswire/ -- YishengBio Co., Ltd ("YishengBio") today announced that it has received IND clearance for PIKA recombinant COVID-19 vaccine to conduct Phase I clinical trial from United Arab Emirates Ministry of Health & Prevention. PIKA recombinant COVID-19 vaccine is a PI...

2021-07-19 09:00 3632

Bioelectronica Announces Hypercell™ Expansion for Antibody Discovery, Closing of Oversubscribed Series A Financing, Powering Local Hiring Growth and Expansion of Facilities in Reno

RENO, Nev., July 19, 2021 /PRNewswire/ -- Bioelectronica® Corporation ("Bioelectronica") announced today that it has secured an undisclosed amount in its Series A financing round due to increased interest in Hypercell™, a new hardware tool that can be used to discover new antibodies using compute...

2021-07-19 08:59 3463

ImmVira Launches Pilot-scale Production Line to Expedite the Advancement of Next-generation OV Clinical Trials

SHENZHEN, China, July 18, 2021 /PRNewswire/ -- On July 18, 2021, ImmVira inaugurated a pilot-scale production line inShenzhen and officially initiated its in-house production of our next-generation oncolytic viruses (OV) used for IND applications and Phase I/II clinical trials. Leveraging a strat...

2021-07-19 08:30 2132

Kintor Pharmaceutical Receives Emergency Use Authorization for Proxalutamide for the Treatment of COVID-19 in Paraguay

SUZHOU, China, July 16, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today announced thatParaguay's Ministry of Public Health and Social Welfare (MSPBS) has granted an emerg...

2021-07-16 14:41 37107

Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI319 (Anti-PD-1/CD137 Bispecific Antibody) in Patients with Advanced Malignant Tumors

SAN FRANCISCO and SUZHOU, China, July 16, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-07-16 08:00 9206

Alterity Therapeutics Announces Publication of Data Demonstrating ATH434 is Neuroprotective and Improves Motor Function

MELBOURNE, Australia, July 15, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, today announced thatMovement Disorders, the official jou...

2021-07-15 21:52 37430

Fortacin™ Receives Strong Positive Results for US Phase II PRO Validation Study

HONG KONG, July 15, 2021 /PRNewswire/ -- Endurance RP Limited ("Endurance Longevity" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK) is pleased to announce the successful completion of prespecified data analysis fromthe United States study mandated patient ...

2021-07-15 21:27 38604

Atonarp announces innovative new metrology platform Aston, aimed at increasing yield, throughput, and efficiency in semiconductor manufacturing processes

TOKYO, July 15, 2021 /PRNewswire/ -- Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the semiconductor, healthcare, and pharma industries, today announcedAston, an innovative in-situ semiconductor metrology platform with an integrated plasma ionization source. ...

2021-07-15 21:15 4350

GlobalMed Technologies Launches Home-Use Omnilux Contour™ Light Therapy Products in Australia & New Zealand

FDA-Cleared LED Devices are Based on the Gold Standard Omnilux Medical™ System NAPA, Calif., July 16, 2021 /PRNewswire/ -- GlobalMed Technologies (GMT) announced today that it has launched theOmnilux Contour™ line of home-use LED light therapy products in Australia and New Zealand. Contour produ...

2021-07-15 20:00 2101

ELITechGroup Acquires GONOTEC, A Leading Market Player In Freezing Point Osmometry

LOGAN, Utah, July 15, 2021 /PRNewswire/ -- ELITechGroup, market leader in global vapor pressure osmometer technology, announces the acquisition of GONOTEC, a leading market player in freezing point osmometer technology. The purchase of the company unites two osmometry market leaders, providing t...

2021-07-15 20:00 3634

Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on July 22 at 9:30 CEST

STOCKHOLM, July 15, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFOElisabet Lund. To register for the presentation of the ...

2021-07-15 16:20 1706

Cigna International finds community spirit and duty to society top driver of COVID-19 vaccine uptake

Key research findings: * Vaccine acceptance continues to improve – steady increase in vaccine acceptance, 69% up from 63% in three months * Urgency has increased – those waiting to get a vaccination until more people have had their first one dropped 8% in three months, from 50% to 42% * Vac...

2021-07-15 15:30 46246

iSTAR Medical receives U.S. FDA approval to start pivotal trial for MINIject in glaucoma patients

WAVRE, Belgium, July 15, 2021 /PRNewswire/ -- iSTAR Medical , a med-tech company developing minimally-invasive implants for glaucoma surgery (MIGS), announced today that the U.S. Food and Drug Administration (FDA) granted it Investigational Device Exemption (IDE) to sta...

2021-07-15 14:00 2448

Transcenta Announces First Patient Dosed in Global Phase I Clinical Trial of PD-L1/TGF-β Bi-functional Antibody TST005

SUZHOU, China, July 15, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announces that the first US patient has been dosed...

2021-07-15 11:23 3018

Kintor Pharmaceutical Collaborates with Fosun Pharma Development to Commercialise Proxalutamide for Treatment of COVID-19 in India and Africa

SUZHOU, China, July 14, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX:9939) today announced that it has entered into a licensing agreement with Shanghai Fosun Pharmaceutical Development Ltd. ("Fosun Pharma Development"), on the commercialisation of proxalutamide for the treatment of CO...

2021-07-15 10:00 34641

Johnson & Johnson Innovation announces extension of innovation partnering office at Monash University in collaboration with Victorian State Government to accelerate the life-sciences hub

- Victorian State Government extends financing of JJIPO@Monash for an additional two years - Extension will further boost Victorian hub for researchers and early-stage companies to connect with industry experts and deliver novel healthcare solutions MELBOURNE, Australia, July 15, 2021 /PRNewswi...

2021-07-15 10:00 2020

Ascentage Pharma and Innovent Biologics Reach Multifaceted Strategic Agreement Totaling US$245 Million Including Commercialization of Olverembatinib (HQP1351) in China, Joint Clinical Development of Lisaftoclax (APG-2575) and Equity Investment

SUZHOU, China, and ROCKVILLE, Md., July 14, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Innovent Biologics (1801.HK, "Innovent"), today an...

2021-07-15 01:43 6455

Innovent and Ascentage Pharma Reach Multifaceted Strategic Agreement including Joint Commercialization of Olverembatinib in China, Joint Clinical Development on Multiple Products, and Equity Investment

SAN FRANCISCO and SUZHOU, China, July 14, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-07-14 23:48 17509
1 ... 626627628629630631632 ... 649